SCHEMBL12431015

SCHEMBL12431015

CN/C(C)=C/C(=O)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1739 1.00
SCHEMBL11708371 1.00 HCAR2 (0.46)
SCHEMBL1740 1.00
SCHEMBL11707587 0.79
SCHEMBL11050866 0.78 TSHR (0.37)
SCHEMBL2326348 0.77 SMN1; SMN2 (0.50)
SCHEMBL2326345 0.77 SMN1; SMN2 (0.50)
SCHEMBL2326353 0.77 SMN1; SMN2 (0.50)
SCHEMBL15459193 0.77
SCHEMBL24793666 0.77 NPSR1 (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250382304-A1 HETEROAROMATIC MACROCYCLIC ETHER CHEMOTHERAPEUTIC AGENTS NUVALENT INC (US) 2025-12-18 US disclosed
US-12454530-B2 Amido cyclohexane acid derivatives as LPA receptor inhibitors CHIESI FARMACEUTICI S.P.A. (IT) 2025-10-28 US disclosed
US-20250188068-A1 AMIDO CYCLOPROPYL DERIVATIVES AS LPA RECEPTOR INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2025-06-12 US disclosed
US-12275742-B2 Heteroaromatic macrocyclic ether chemotherapeutic agents NUVALENT, INC. (US) 2025-04-15 US disclosed
US-20250066341-A1 CYCLOHEXANE ACID DERIVATIVES AS LPA RECEPTOR INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2025-02-27 US disclosed
EP-4490150-A1 AMIDO CYCLOPROPYL DERIVATIVES AS LPA RECEPTOR INHIBITORS Chiesi Farmaceutici S.p.A. (IT) 2025-01-15 EP disclosed
EP-4452965-A1 CYCLOHEXANE ACID DERIVATIVES AS LPA RECEPTOR INHIBITORS Chiesi Farmaceutici S.p.A. (IT) 2024-10-30 EP disclosed
EP-4182301-B1 AMIDO CYCLOHEXANE ACID DERIVATIVES AS LPA RECEPTOR INHIBITORS CHIESI FARM SPA (IT) 2024-09-04 EP disclosed
WO-2023170025-A1 AMIDO CYCLOPROPYL DERIVATIVES AS LPA RECEPTOR INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2023-09-14 WO disclosed
US-20230250093-A1 AMIDO CYCLOHEXANE ACID DERIVATIVES AS LPA RECEPTOR INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2023-08-10 US disclosed
US-20150299383-A1 FOAM COMPOSITIONS AMRIZE TECHNOLOGY SWITZERLAND LLC (CH) 2015-10-22 US disclosed
US-8785442-B2 Compound as antagonist of lysophosphatidic acid receptor, composition, and use thereof CUREGENIX, INC. (CN) 2014-07-22 US disclosed
US-8785442-B2 Compound as antagonist of lysophosphatidic acid receptor, composition, and use thereof CUREGENIX, INC. (CN) 2014-07-22 US disclosed
US-8785442-B2 Compound as antagonist of lysophosphatidic acid receptor, composition, and use thereof CUREGENIX, INC. (CN) 2014-07-22 US disclosed
US-20140031353-A1 COMPOUND AS ANTAGONIST OF LYSOPHOSPHATIDIC ACID RECEPTOR, COMPOSITION, AND USE THEREOF CUREGENIX, INC. (CN) 2014-01-30 US disclosed
US-20140031353-A1 COMPOUND AS ANTAGONIST OF LYSOPHOSPHATIDIC ACID RECEPTOR, COMPOSITION, AND USE THEREOF CUREGENIX, INC. (CN) 2014-01-30 US disclosed
US-20140031353-A1 COMPOUND AS ANTAGONIST OF LYSOPHOSPHATIDIC ACID RECEPTOR, COMPOSITION, AND USE THEREOF CUREGENIX, INC. (CN) 2014-01-30 US disclosed
WO-2012100436-A1 COMPOUND AS ANTAGONIST OF LYSOPHOSPHATIDIC ACID RECEPTOR, COMPOSITION, AND USE THEREOF CUREGENIX INC. (CN) 2012-08-02 WO disclosed
US-7981950-B2 Dispersant-encapsulated particulate solids FUJIFILM IMAGING COLORANTS LIMITED (GB) 2011-07-19 US disclosed
US-20070263050-A1 Process FUJIFILM IMAGING COLORANTS LIMITED (GB) 2007-11-15 US disclosed